Iovance Biotherapeutics, Inc. (IOVA)
7.63
-0.46
(-5.69%)
USD |
NASDAQ |
Nov 12, 16:00
7.66
+0.03
(+0.39%)
After-Hours: 07:24
Iovance Biotherapeutics Market Cap : 3.529B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 3.529B |
| November 11, 2026 | 3.742B |
| November 10, 2026 | 3.737B |
| November 09, 2026 | 3.779B |
| November 06, 2026 | 3.719B |
| November 05, 2026 | 3.580B |
| November 04, 2026 | 4.024B |
| November 03, 2026 | 4.084B |
| November 02, 2026 | 3.633B |
| October 30, 2026 | 3.841B |
| October 29, 2026 | 4.330B |
| October 28, 2026 | 6.709B |
| October 27, 2026 | 6.604B |
| October 26, 2026 | 6.242B |
| October 23, 2026 | 6.382B |
| October 22, 2026 | 6.405B |
| October 21, 2026 | 6.622B |
| October 20, 2026 | 6.731B |
| October 19, 2026 | 6.437B |
| October 16, 2026 | 6.169B |
| October 15, 2026 | 6.668B |
| October 14, 2026 | 6.437B |
| October 13, 2026 | 6.568B |
| October 12, 2026 | 6.595B |
| October 09, 2026 | 6.622B |
| Date | Value |
|---|---|
| October 08, 2026 | 6.029B |
| October 07, 2026 | 5.850B |
| October 06, 2026 | 5.871B |
| October 05, 2026 | 6.410B |
| October 02, 2026 | 6.439B |
| October 01, 2026 | 6.446B |
| September 30, 2026 | 6.713B |
| September 29, 2026 | 6.545B |
| September 28, 2026 | 4.978B |
| September 25, 2026 | 4.983B |
| September 24, 2026 | 4.892B |
| September 23, 2026 | 4.616B |
| September 22, 2026 | 4.820B |
| September 21, 2026 | 4.616B |
| September 18, 2026 | 4.643B |
| September 17, 2026 | 4.539B |
| September 16, 2026 | 4.471B |
| September 15, 2026 | 4.240B |
| September 14, 2026 | 4.195B |
| September 11, 2026 | 3.896B |
| September 10, 2026 | 3.687B |
| September 09, 2026 | 3.819B |
| September 08, 2026 | 3.941B |
| September 04, 2026 | 3.982B |
| September 03, 2026 | 3.941B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AVITA Medical, Inc. | 501.59M |
| Halozyme Therapeutics, Inc. | 11.47B |
| CareDx, Inc. | 4.187B |
| Merck & Co., Inc. | 362.49B |
| SELLAS Life Sciences Group, Inc. | 1.621B |
Market Cap Related Metrics
| PS Ratio | 8.717 |
| Price to Book Value | 4.343 |
| Price | 7.63 |
| Earnings Yield | -6.81% |